Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Chinese Patent Office
Daiichi Sankyo
Teva
Cantor Fitzgerald
Deloitte
Healthtrust
Covington
AstraZeneca

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074222

« Back to Dashboard

NDA 074222 describes EMBELINE, which is a drug marketed by Hi Tech Pharma and is included in four NDAs. It is available from four suppliers. Additional details are available on the EMBELINE profile page.

The generic ingredient in EMBELINE is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 074222
Tradename:EMBELINE
Applicant:Hi Tech Pharma
Ingredient:clobetasol propionate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 074222
Medical Subject Heading (MeSH) Categories for 074222
Suppliers and Packaging for NDA: 074222
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EMBELINE clobetasol propionate SOLUTION;TOPICAL 074222 ANDA Hi-Tech Pharmacal Co., Inc. 50383-266 50383-266-50 1 BOTTLE in 1 CARTON (50383-266-50) > 50 mL in 1 BOTTLE
EMBELINE clobetasol propionate SOLUTION;TOPICAL 074222 ANDA Hi-Tech Pharmacal Co., Inc. 50383-266 50383-266-25 1 BOTTLE in 1 CARTON (50383-266-25) > 25 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;TOPICALStrength0.05%
Approval Date:Dec 6, 1995TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Moodys
Boehringer Ingelheim
Dow
Citi
QuintilesIMS
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot